The best take-home messages from the 2012 American Urological Association annual meeting in Atlanta
Here are the take-home messages from the 2012 AUA annual meeting-cutting-edge research findings in 15 areas of clinical urology.
Atlanta-The U.S. Preventive Services Task Force's announcement that it was sticking with its grade D recommendation on prostate cancer screening came at the midpoint of the 2012 AUA annual meeting here. Conversations everywhere, from the scientific sessions to hotel lobbies, quickly turned to analysis and opinion of the controversial announcement.
Although it hardly seemed so at the time, other news came out of the meeting in the form of cutting-edge research findings in a broad array of clinical areas. Beginning here, Urology Times presents "The Best of AUA," our report on the meeting's take-home messages, which were pared down to 15 topics this year in a shortened meeting format. Messages identified by our editors as particularly high interest are highlighted in red.
PROSTATE CANCER
INFECTION/INFLAMMATION
PRESENTED BY
STONE DISEASE & ENDOUROLOGY
PRESENTED BY
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.
Phase 1B trial to evaluate relugolix and enzalutamide in high-risk prostate cancer
July 24th 2024"Going forward after this study, we hope to be able to expand and potentially look at patients undergoing either surgery or radiation therapy, and really try to determine the potential benefit," says Kelly L. Stratton, MD, FACS.
